SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-246314
Filing Date
2020-09-15
Accepted
2020-09-15 17:19:01
Documents
7
Period of Report
2020-09-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d26397d8k.htm 8-K 68411
2 EX-2.1 d26397dex21.htm EX-2.1 1108921
3 EX-3.1 d26397dex31.htm EX-3.1 83734
4 EX-10.1 d26397dex101.htm EX-10.1 351893
5 EX-10.2 d26397dex102.htm EX-10.2 118491
6 EX-99.1 d26397dex991.htm EX-99.1 22356
7 GRAPHIC g26397g0915072517616.jpg GRAPHIC 2789
  Complete submission text file 0001193125-20-246314.txt   1759474
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Novus Therapeutics, Inc. (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36620 | Film No.: 201176766
SIC: 2834 Pharmaceutical Preparations